Item Type | Name |
Concept
|
Forced Expiratory Volume
|
Academic Article
|
Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.
|
Academic Article
|
Diagnosis of unilateral mainstem bronchial obstruction following single-lung transplantation with routine spirometry.
|
Academic Article
|
Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation.
|
Academic Article
|
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
|
Academic Article
|
Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction.
|
Academic Article
|
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
|
Academic Article
|
Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.
|
Academic Article
|
Physiological and computed tomographic predictors of outcome from lung volume reduction surgery.
|
Academic Article
|
Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps.
|
Academic Article
|
Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial.
|
Academic Article
|
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.
|
Academic Article
|
Older adults with chronic lung disease report less limitation compared with younger adults with similar lung function impairment.
|
Academic Article
|
Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.
|
Academic Article
|
The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations.
|
Academic Article
|
Assessment of patients with chronic obstructive pulmonary disease.
|
Academic Article
|
Local heterogeneity of normal lung parenchyma and small airways disease are associated with COPD severity and progression.
|
Academic Article
|
Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Vessel and Airway Characteristics in One-Year Computed Tomography-defined Rapid Emphysema Progression: SPIROMICS.
|
Academic Article
|
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
|
Academic Article
|
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology.
|
Academic Article
|
Predictors of mortality in patients with emphysema and severe airflow obstruction.
|
Academic Article
|
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review.
|
Academic Article
|
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
|
Academic Article
|
Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
|
Academic Article
|
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS.
|
Academic Article
|
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
|
Academic Article
|
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
|
Academic Article
|
Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
|
Academic Article
|
Chronic obstructive pulmonary disease phenotypes: the future of COPD.
|
Academic Article
|
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Ratio of FEV1/Slow Vital Capacity of?< 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
|
Academic Article
|
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.
|
Academic Article
|
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.
|
Academic Article
|
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
|
Academic Article
|
Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
|
Academic Article
|
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.
|
Academic Article
|
Cigarette smoking and response to inhaled corticosteroids in COPD.
|
Academic Article
|
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
|
Academic Article
|
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
|
Academic Article
|
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline.
|
Academic Article
|
Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS.
|
Academic Article
|
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
|
Academic Article
|
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
|
Academic Article
|
Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort.
|
Academic Article
|
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
|
Academic Article
|
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
|
Academic Article
|
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers.
|
Academic Article
|
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
|
Academic Article
|
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.
|
Academic Article
|
A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD.
|
Academic Article
|
A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Effects of baseline symptom burden on treatment response in COPD.
|
Academic Article
|
Metoprolol for the Prevention of Acute Exacerbations of COPD.
|
Academic Article
|
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
|
Academic Article
|
CT metrics of airway disease and emphysema in severe COPD.
|
Academic Article
|
Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease.
|
Academic Article
|
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.
|
Academic Article
|
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
|
Academic Article
|
The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS.
|
Academic Article
|
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
|
Academic Article
|
Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial.
|
Academic Article
|
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.
|
Academic Article
|
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
|
Academic Article
|
Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.
|
Academic Article
|
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
|
Academic Article
|
Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial.
|
Academic Article
|
Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
|
Academic Article
|
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.
|
Academic Article
|
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
|
Academic Article
|
Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy.
|
Academic Article
|
Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS.
|